Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND application for phase I/II study of OBI-999

Sep. 4, 2019

Four-way interaction screen gives clues to drug effects

Sep. 4, 2019

Vulnerable brains can be steered towards healthy development

Sep. 4, 2019

Discovery and preclinical characterization of c-KIT kinase inhibitor CHMFL-KIT-64

Sep. 4, 2019

Targeted protein degradation with DGY-08-097 shows promise for hepatitis C virus treatment

Sep. 4, 2019

Boehringer Ingelheim to advance BI-456906 into phase II for obesity and diabetes

Sep. 3, 2019

Grunenthal and UniQuest establish neuropathic pain collaboration

Sep. 3, 2019

Twinrab approved in India for rabies

Sep. 3, 2019

FDA approves Kuros' IND for phase IIa trial of KUR-113 for spinal fusion

Sep. 3, 2019

ObsEva reports mechanism-of-action data on oxytocin receptor antagonist nolasiban

Sep. 3, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...